Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

22 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Glenmark Pharmaceuticals Articles

Briefs: Glenmark challenges Bayer patent; FDA delays Merck & Co's sugammadex

18 March 2013

Forest in patent settlement with Glenmark; Watson generic Lysteda cleared; and Dr Reddy's debuts generic Propecia

3 January 2013

Forest Labs and Glenmark collaborate; Takeda and Amylin cancel obesity accord

27 December 2012

ICDR rules in favor of Glenmark over Crofelemer

23 August 2012

Salix files Crofelemer NDA as spat with Napo moves to Glenmark

15 December 2011

Glenmark sells rights to Crohn’s drug to Sanofi for up to $613 million

17 May 2011

Merck & Co settles US patent dispute over Zetia with Glenmark

11 May 2010

India’s Glenmark surges on up to $325 million deal with Sanofi-Aventis for pain compounds

4 May 2010

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Is failure to adopt business process management putting the pharma industry at risk?
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Elan makes "transformational" acquisitions and a divestment
  • Is failure to adopt business process management putting the pharma industry at risk?
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Elan makes "transformational" acquisitions and a divestment

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS